Anti-cytokine therapy in fibrosing alveolitis: where are we now?
Idiopathic pulmonary fibrosis (IPF) is a condition that has a poor prognosis, with a median survival of 4-5 years irrespective of treatment. Ziesche et al (N Engl J Med 1999, 341: 1264-1269) describe an open randomised trial of 18 patients with IPF, unresponsive to corticosteroid treatment at high d...
Na minha lista:
| Publicado no: | Respir Res |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC59532/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11667955/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/rr2 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|